Adient plc designs, manufactures, and markets a range of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's products include frames, mechanisms, foams, head restraints, armrests, and trim covers. It serves automotive original equipment manufacturers in the Americas, Europe, China, and internationally. The company was incorporated in 2016 and is based in Dublin, Ireland.
IPO Year: 2016
Exchange: NYSE
Website: adient.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
4/23/2025 | $14.00 | Neutral | Citigroup |
3/4/2025 | $24.00 → $18.00 | Neutral → Underperform | BofA Securities |
12/16/2024 | $27.00 → $20.00 | Overweight → Equal Weight | Wells Fargo |
11/21/2024 | $30.00 → $24.00 | Buy → Neutral | BofA Securities |
9/10/2024 | $24.00 | Hold | Deutsche Bank |
9/5/2024 | Peer Perform | Wolfe Research | |
7/1/2024 | $26.00 | Underperform → Neutral | Exane BNP Paribas |
4/10/2024 | $41.00 → $37.00 | Overweight → Equal Weight | Barclays |
9/13/2023 | $43.00 | Neutral | UBS |
6/1/2023 | Neutral → Underperform | Exane BNP Paribas |
4 - Adient plc (0001670541) (Issuer)
4 - Adient plc (0001670541) (Issuer)
4 - Adient plc (0001670541) (Issuer)
4 - Adient plc (0001670541) (Issuer)
4 - Adient plc (0001670541) (Issuer)
4 - Adient plc (0001670541) (Issuer)
4 - Adient plc (0001670541) (Issuer)
4 - Adient plc (0001670541) (Issuer)
4 - Adient plc (0001670541) (Issuer)
4 - Adient plc (0001670541) (Issuer)
Citigroup initiated coverage of Adient with a rating of Neutral and set a new price target of $14.00
BofA Securities downgraded Adient from Neutral to Underperform and set a new price target of $18.00 from $24.00 previously
Wells Fargo downgraded Adient from Overweight to Equal Weight and set a new price target of $20.00 from $27.00 previously
BofA Securities downgraded Adient from Buy to Neutral and set a new price target of $24.00 from $30.00 previously
Deutsche Bank resumed coverage of Adient with a rating of Hold and set a new price target of $24.00
Wolfe Research resumed coverage of Adient with a rating of Peer Perform
Exane BNP Paribas upgraded Adient from Underperform to Neutral and set a new price target of $26.00
Barclays downgraded Adient from Overweight to Equal Weight and set a new price target of $37.00 from $41.00 previously
UBS initiated coverage of Adient with a rating of Neutral and set a new price target of $43.00
Exane BNP Paribas downgraded Adient from Neutral to Underperform